Clinical predictors of therapeutic response to antipsychotics in schizophrenia

• Published in: Dialogues in clinical neuroscience 2014-12, Vol.16 (4), p.505-524
• Main Authors: Carbon, Maren, Correll, Christoph U.
• Format: Article
• Language: English
• Subjects: Antipsychotic Agents - therapeutic use; association; Clinical Research; Humans; marker; predictor; psychosis; remission; response; Risk Factors; schizophrenia; Schizophrenia - drug therapy; Schizophrenic Psychology
• ISSN: 1958-5969; 1294-8322; 1958-5969
• DOI: 10.31887/DCNS.2014.16.4/mcarbon

The search for clinical outcome predictors for schizophrenia is as old as the field of psychiatry. However, despite a wealth of large, longitudinal studies into prognostic factors, only very few clinically useful outcome predictors have been identified. The goal of future treatment is to either affect modifiable risk factors, or use nonmodifiable factors to parse patients into therapeutically meaningful subgroups. Most clinical outcome predictors are nonspecific and/or nonmodifiable. Nonmodifiable predictors for poor odds of remission include male sex, younger age at disease onset, poor premorbid adjustment, and severe baseline psychopathology. Modifiable risk factors for poor therapeutic outcomes that clinicians can act upon include longer duration of untreated illness, nonadherence to antipsychotics, comorbidities (especially substance-use disorders), lack of early antipsychotic response, and lack of improvement with non-clozapine antipsychotics, predicting clozapine response. It is hoped that this limited capacity for prediction will improve as pathophysiological understanding increases and/or new treatments for specific aspects of schizophrenia become available.